RNA Interference Therapeutics Targeting Hepatic Gluconeogenesis Pathways in Type 2 Diabetes Management
2026 | IDOSR JOURNAL OF EXPERIMENTAL SCIENCES | Pp. 115-119
Type 2 diabetes mellitus was characterized by chronic hyperglycemia resulting from insulin resistance and impaired regulation of hepatic glucose production. Excessive hepatic gluconeogenesis was a major contributor to fasting hyperglycemia and remained incomp...